Giuseppe Nunnari to Humans
This is a "connection" page, showing publications Giuseppe Nunnari has written about Humans.
Connection Strength
0.115
-
SARS-CoV-2 related paediatric acute-onset neuropsychiatric syndrome. Lancet Child Adolesc Health. 2021 06; 5(6):e19-e21.
Score: 0.008
-
Comment on safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: a nationwide comparative analysis. Eur Rev Med Pharmacol Sci. 2021 03; 25(6):2473-2474.
Score: 0.007
-
Network perturbation analysis in human bronchial epithelial cells following SARS-CoV2 infection. Exp Cell Res. 2020 10 15; 395(2):112204.
Score: 0.007
-
Diversity of clinical appearance of cutaneous manifestations in the course of COVID-19. J Eur Acad Dermatol Venereol. 2020 Sep; 34(9):e449-e450.
Score: 0.007
-
Silent COVID-19: what your skin can reveal. Lancet Infect Dis. 2021 01; 21(1):24-25.
Score: 0.007
-
Outbreak of COVID-19 infection in children: fear and serenity. Eur Rev Med Pharmacol Sci. 2020 04; 24(8):4572-4575.
Score: 0.007
-
Risk factors of venous thrombo-embolism during cytomegalovirus infection in immunocompetent individuals. A systematic review. Eur J Clin Microbiol Infect Dis. 2018 Mar; 37(3):381-390.
Score: 0.006
-
Hepatitis C-related hepatocellular carcinoma: diagnostic and therapeutic management in HIV-patients. Eur Rev Med Pharmacol Sci. 2017 12; 21(24):5859-5867.
Score: 0.006
-
Trimethoprim-sulfamethoxazole-associated severe hypoglycaemia: a sulfonylurea-like effect. Eur Rev Med Pharmacol Sci. 2010 Dec; 14(12):1015-8.
Score: 0.004
-
Clinical application of lung ultrasound score on COVID-19 setting: a regional experience in Southern Italy. Eur Rev Med Pharmacol Sci. 2021 May; 25(9):3623-3631.
Score: 0.002
-
Reasons why COVID-19 survivors should follow dietary World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) recommendations: from hyper-inflammation to cardiac dysfunctions. Eur Rev Med Pharmacol Sci. 2021 May; 25(10):3898-3907.
Score: 0.002
-
HLA-C*17 in COVID-19 patients: Hints for associations with severe clinical outcome and cardiovascular risk. Immunol Lett. 2021 06; 234:44-46.
Score: 0.002
-
Favourable course in a cohort of Parkinson's disease patients infected by SARS-CoV-2: a single-centre experience. Neurol Sci. 2021 Mar; 42(3):811-816.
Score: 0.002
-
New generation biologics for the treatment of psoriasis and psoriatic arthritis. State of the art and considerations about the risk of infection. Dermatol Ther. 2021 Jan; 34(1):e14660.
Score: 0.002
-
Ocular surface manifestation of COVID-19 and tear film analysis. Sci Rep. 2020 11 19; 10(1):20178.
Score: 0.002
-
Chilblains-like lesions and SARS-CoV-2 in children: An overview in therapeutic approach. Dermatol Ther. 2021 Jan; 34(1):e14502.
Score: 0.002
-
Asymptomatic COVID-19 infection in patients with cancer at a cancer-specialized hospital in Wuhan, China - Preliminary results. Eur Rev Med Pharmacol Sci. 2020 11; 24(21):10924-10925.
Score: 0.002
-
Management of pernio-like cutaneous manifestations in children during the outbreak of COVID-19. Dermatol Ther. 2020 11; 33(6):e14312.
Score: 0.002
-
A Case of COVID-19 with Late-Onset Rash and Transient Loss of Taste and Smell in a 15-Year-Old Boy. Am J Case Rep. 2020 Aug 20; 21:e925813.
Score: 0.002
-
Editorial - Coronavirus disease 2019 and people living with HIV: clinical considerations. Eur Rev Med Pharmacol Sci. 2020 07; 24(13):7534-7539.
Score: 0.002
-
Transmission mode associated with coronavirus disease 2019: a review. Eur Rev Med Pharmacol Sci. 2020 07; 24(14):7889-7904.
Score: 0.002
-
In the face of the SARS-CoV-2 outbreak, do people suffering from oncological disease need specific attention? Eur Rev Med Pharmacol Sci. 2020 04; 24(7):3434-3436.
Score: 0.002
-
Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience. Eur Rev Med Pharmacol Sci. 2020 04; 24(7):4040-4047.
Score: 0.002
-
Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet? Eur Rev Med Pharmacol Sci. 2020 03; 24(5):2781-2783.
Score: 0.002
-
Hepatitis B vaccination coverage among medical residents from Catania University Hospital, Italy. Future Microbiol. 2019 Jun; 14:41-44.
Score: 0.002
-
Vaccine-preventable disease in healthcare workers in Sicily (Italy): seroprevalence against measles. Future Microbiol. 2019 Jun; 14:33-36.
Score: 0.002
-
Tuberculosis screening among healthcare workers in Sicily, Italy. Future Microbiol. 2019 Jun; 14:37-40.
Score: 0.002
-
Breast cancer in women living with HIV. Eur Rev Med Pharmacol Sci. 2019 Feb; 23(3):1158-1164.
Score: 0.002
-
The role of the hospital environment in the healthcare-associated infections: a general review of the literature. Eur Rev Med Pharmacol Sci. 2019 Feb; 23(3):1266-1278.
Score: 0.002
-
Investigational drugs in HIV: Pros and cons of entry and fusion inhibitors (Review). Mol Med Rep. 2019 Mar; 19(3):1987-1995.
Score: 0.002
-
HIV-associated psoriasis: Epidemiology, pathogenesis, and management. Dermatol Ther. 2019 03; 32(2):e12806.
Score: 0.002
-
Outbreak of Brucella melitensis infection in Eastern Sicily: risk factors, clinical characteristics and complication rate. New Microbiol. 2019 Jan; 42(1):43-48.
Score: 0.002
-
Carbon nanotubes and central nervous system: Environmental risks, toxicological aspects and future perspectives. Environ Toxicol Pharmacol. 2019 Jan; 65:23-30.
Score: 0.002
-
Expression of the OAS Gene Family Is Highly Modulated in Subjects Affected by Juvenile Dermatomyositis, Resembling an Immune Response to a dsRNA Virus Infection. Int J Mol Sci. 2018 Sep 17; 19(9).
Score: 0.002
-
Tache Noire in a Patient with Acute Q Fever. Med Princ Pract. 2018; 27(1):92-94.
Score: 0.001
-
Kaposi's sarcoma in HIV-infected patients in the era of new antiretrovirals. Eur Rev Med Pharmacol Sci. 2017 12; 21(24):5868-5869.
Score: 0.001
-
SERPING1 mRNA overexpression in monocytes from HIV+ patients. Inflamm Res. 2017 Dec; 66(12):1107-1116.
Score: 0.001
-
Cardiovascular risk and dyslipidemia among persons living with HIV: a review. BMC Infect Dis. 2017 08 09; 17(1):551.
Score: 0.001
-
PrEP in Italy: The time may be ripe but who's paying the bill? A nationwide survey on physicians' attitudes towards using antiretrovirals to prevent HIV infection. PLoS One. 2017; 12(7):e0181433.
Score: 0.001
-
Attitude of Health Care Workers (HCWs) toward Patients Affected by HIV/AIDS and Drug Users: A Cross-Sectional Study. Int J Environ Res Public Health. 2017 03 09; 14(3).
Score: 0.001
-
OAS Gene Family Expression Is Associated with HIV-Related Neurocognitive Disorders. Mol Neurobiol. 2018 03; 55(3):1905-1914.
Score: 0.001
-
Use of statins and aspirin to prevent cardiovascular disease among HIV-positive patients. A survey among Italian HIV physicians. New Microbiol. 2017 Apr; 40(2):139-142.
Score: 0.001
-
Kawasaki's disease with paralytic ileus. A case report. Minerva Pediatr. 2006 Apr; 58(2):193-7.
Score: 0.001
-
Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapy. J Infect Dis. 2002 Nov 15; 186(10):1403-11.
Score: 0.001